Thanks very much. I'm pleased to say that I have followed up on that debate, and one of the things that I've done is to hold a cancer summit meeting, where, obviously, we looked at the breakdown of where we need to make further progress in relation in particular to gynaecological cancer. We're putting pressure on health boards to make sure that they understand what are the optimum pathways, to make sure that they can learn from each other. One of the key purposes of these cancer summits is that they understand what is the optimal pathway, following the best clinical advice. So, there has been progress, I'm pleased to say. I think we've got a long way to go, if I'm honest. Some of that is about workforce, but obviously, we'll be making announcements soon about what we plan to do in the workforce space.